Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas.
Cutaneous T-cell lymphomas (CTCL) are mainly comprised of two variants: mycosis fungoides (MF) with CD4(+) tumor cells confined to the skin and the leukemic Sézary syndrome with tumor cell spread to the blood. In this study, we investigated cutaneous expression of the regulatory T-cell (T(reg)) mark...
Main Authors: | Klemke, C, Fritzsching, B, Franz, B, Kleinmann, E, Oberle, N, Poenitz, N, Sykora, J, Banham, A, Roncador, G, Kuhn, A, Goerdt, S, Krammer, P, Suri-Payer, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
FOXP3+ regulatory T cells: Current controversies and future perspectives.
by: Banham, A, et al.
Published: (2006) -
Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients.
by: Benedikt Fritzsching, et al.
Published: (2011-01-01) -
FOXP3 expression in B and T cell lymphomas.
by: Roncador, G, et al.
Published: (2005) -
TOX Expression in Mycosis Fungoides and Sezary Syndrome
by: Alessandro Pileri, et al.
Published: (2022-06-01) -
Single-cell heterogeneity in Sézary syndrome
by: Terkild Brink Buus, et al.
Published: (2018-08-01)